| Literature DB >> 10727129 |
A R Khan1, M J Akhtar, R Mahmood, S M Ahmed, S Malook, M Iqbal.
Abstract
A method has been developed for the simultaneous determination of oxfendazole and oxyclozanide in a pharmaceutical preparation. The method involves reversed phase chromatography with isocratic elution of the mobile phase and detection at 300 nm. The range of quantification for oxfendazole and oxyclozanide was found to be 2-7 microg ml(-1) and 3-10 microg ml(-1), respectively. The validity of the method was evaluated in terms of linear regression analysis, precision, specificity and accuracy.Entities:
Mesh:
Substances:
Year: 2000 PMID: 10727129 DOI: 10.1016/s0731-7085(99)00260-5
Source DB: PubMed Journal: J Pharm Biomed Anal ISSN: 0731-7085 Impact factor: 3.935